A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

NCT00257478 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Cancer of Prostate
Prostatic Cancer
Cancer of the Prostate

Interventions

DRUG: YM155

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]